Portfolio Holdings Detail for ISIN IE00BYZK4776
Stock Name / FundiShares Healthcare Innovation UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerDRDR(GBX) LSE
ETF Ticker2B78(EUR) F
ETF Ticker2B78.DE(EUR) CXE
ETF TickerDRDR.LS(GBX) CXE
ETF TickerHEAL.AS(EUR) CXE
ETF TickerHEAL.LS(USD) CXE
ETF TickerHEALz(USD) CXE
ETF TickerHEAL(EUR) ETF Plus
ETF TickerDRDR.L(GBP) LSE

Holdings detail for NVRO

Stock NameNevro Corp
TickerNVRO(USD) NYSE
TYPECommon Stock
CountryUSA
ISINUS64157F1030
LEI254900SH91I4BOYKUE38

Show aggregate NVRO holdings

News associated with NVRO

SG Americas Securities LLC Acquires 38,264 Shares of Nevro Corp. (NYSE:NVRO)
SG Americas Securities LLC increased its holdings in Nevro Corp. (NYSE:NVRO – Free Report) by 223.4% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,390 shares of the medical equipment provider’s stock after acquiring an additional 38,264 shares during […] - 2025-06-26 04:28:52
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 68,022 Shares of Nevro Corp. (NYSE:NVRO)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC trimmed its position in shares of Nevro Corp. (NYSE:NVRO – Free Report) by 6.8% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 931,978 shares of the medical equipment provider’s stock after […] - 2025-06-05 05:12:54
Nuveen Asset Management LLC Acquires 17,878 Shares of Nevro Corp. (NYSE:NVRO)
Nuveen Asset Management LLC lifted its holdings in Nevro Corp. (NYSE:NVRO – Free Report) by 5.1% during the fourth quarter, HoldingsChannel.com reports. The firm owned 369,554 shares of the medical equipment provider’s stock after purchasing an additional 17,878 shares during the period. Nuveen Asset Management LLC’s holdings in Nevro were worth $1,375,000 as of its […] - 2025-06-04 04:40:51
State of Wyoming Has $115,000 Stake in Nevro Corp. (NYSE:NVRO)
State of Wyoming grew its holdings in shares of Nevro Corp. (NYSE:NVRO – Free Report) by 55.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 31,043 shares of the medical equipment provider’s stock after acquiring an additional 11,091 shares during […] - 2025-05-27 05:19:01
Nevro (NYSE:NVRO) Coverage Initiated at StockNews.com
Investment analysts at StockNews.com started coverage on shares of Nevro (NYSE:NVRO – Get Free Report) in a research report issued to clients and investors on Saturday. The brokerage set a “hold” rating on the medical equipment provider’s stock. A number of other equities analysts have also commented on the stock. Piper Sandler upgraded shares of […] - 2025-05-19 02:24:56
Barclays PLC Boosts Stock Holdings in Nevro Corp. (NYSE:NVRO)
Barclays PLC boosted its stake in shares of Nevro Corp. (NYSE:NVRO – Free Report) by 12.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 69,416 shares of the medical equipment provider’s stock after purchasing an additional 7,920 shares during the period. […] - 2025-05-12 06:28:46
Nevro (NYSE:NVRO) Earns Hold Rating from Analysts at StockNews.com
Investment analysts at StockNews.com started coverage on shares of Nevro (NYSE:NVRO – Get Free Report) in a research report issued to clients and investors on Tuesday. The brokerage set a “hold” rating on the medical equipment provider’s stock. Several other research firms also recently issued reports on NVRO. Piper Sandler upgraded Nevro from a “neutral” […] - 2025-04-15 02:45:05
Nevro (NYSE:NVRO) Now Covered by Analysts at StockNews.com
StockNews.com started coverage on shares of Nevro (NYSE:NVRO – Free Report) in a report released on Monday morning. The brokerage issued a hold rating on the medical equipment provider’s stock. Several other brokerages have also recently weighed in on NVRO. Wells Fargo & Company decreased their target price on Nevro from $5.00 to $4.00 and […] - 2025-04-08 02:35:04
Blair William & Co. IL Lowers Holdings in Nevro Corp. (NYSE:NVRO)
Blair William & Co. IL decreased its position in Nevro Corp. (NYSE:NVRO – Free Report) by 20.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 37,829 shares of the medical equipment provider’s stock after selling 9,675 shares during the quarter. Blair […] - 2025-04-07 04:48:48
Nevro Corp. (NYSE:NVRO) Receives Consensus Recommendation of “Reduce” from Brokerages
Shares of Nevro Corp. (NYSE:NVRO – Get Free Report) have earned a consensus rating of “Reduce” from the thirteen brokerages that are presently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the company. […] - 2025-03-28 04:28:44
Nevro Corp. (NYSE:NVRO) Receives $6.43 Consensus Target Price from Brokerages
Nevro Corp. (NYSE:NVRO – Get Free Report) has earned a consensus rating of “Reduce” from the thirteen research firms that are covering the company, Marketbeat reports. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the company. The average 12 […] - 2025-03-06 06:08:13
Nevro (NYSE:NVRO) Coverage Initiated by Analysts at StockNews.com
Analysts at StockNews.com initiated coverage on shares of Nevro (NYSE:NVRO – Get Free Report) in a research note issued on Thursday. The brokerage set a “hold” rating on the medical equipment provider’s stock. Several other equities analysts have also recently commented on NVRO. Royal Bank of Canada reissued a “sector perform” rating and issued a […] - 2025-03-06 05:15:00
Comparing Nevro (NYSE:NVRO) and Adynxx (OTCMKTS:ADYX)
Nevro (NYSE:NVRO – Get Free Report) and Adynxx (OTCMKTS:ADYX – Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation. Insider and Institutional Ownership 95.5% of Nevro shares are held […] - 2025-02-20 04:14:51
Nevro (NYSE:NVRO) Coverage Initiated at StockNews.com
Investment analysts at StockNews.com began coverage on shares of Nevro (NYSE:NVRO – Get Free Report) in a research note issued to investors on Tuesday. The firm set a “hold” rating on the medical equipment provider’s stock. A number of other equities research analysts have also issued reports on NVRO. Royal Bank of Canada reissued a […] - 2025-02-18 04:16:54
Nevro (NYSE:NVRO) Stock Rating Upgraded by Jefferies Financial Group
Nevro (NYSE:NVRO – Get Free Report) was upgraded by research analysts at Jefferies Financial Group from an “underperform” rating to a “hold” rating in a research note issued to investors on Monday, MarketBeat Ratings reports. The firm currently has a $5.85 price target on the medical equipment provider’s stock, up from their prior price target […] - 2025-02-12 04:25:00

iShares Healthcare Innovation UCITS ETF USD (Acc) NVRO holdings

DateNumber of NVRO Shares HeldBase Market Value of NVRO SharesLocal Market Value of NVRO SharesChange in NVRO Shares HeldChange in NVRO Base ValueCurrent Price per NVRO Share HeldPrevious Price per NVRO Share Held
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of NVRO by Blackrock for IE00BYZK4776

Show aggregate share trades of NVRO

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-03-31SELL-404 5.840* 5.10 Profit of 2,059 on sale
2025-03-21SELL-396 5.770* 5.05 Profit of 1,999 on sale
2025-03-12SELL-207 5.780* 4.98 Profit of 1,031 on sale
2025-02-28SELL-207 5.720* 4.90 Profit of 1,013 on sale
2025-02-25BUY207 5.730* 4.86
2025-02-20SELL-207 5.730* 4.82 Profit of 998 on sale
2025-02-19BUY414 5.710* 4.81
2025-02-18BUY207 5.720* 4.79
2025-01-22SELL-207 4.900* 4.56 Profit of 945 on sale
2025-01-17SELL-207 4.570* 4.56 Profit of 944 on sale
2024-12-30SELL-414 3.720* 4.77 Profit of 1,974 on sale
2024-12-06SELL-190 4.190* 4.82 Profit of 915 on sale
2024-12-04SELL-191 4.140* 4.87 Profit of 930 on sale
2024-12-03SELL-386 4.260* 4.89 Profit of 1,887 on sale
2024-11-21SELL-207 4.360* 5.06 Profit of 1,048 on sale
2024-11-20SELL-207 4.230* 5.11 Profit of 1,058 on sale
2024-11-19SELL-207 4.240* 5.16 Profit of 1,069 on sale
2024-11-18SELL-808 4.290* 5.22 Profit of 4,215 on sale
2024-11-12SELL-198 5.060* 5.23 Profit of 1,035 on sale
2024-11-07SELL-197 5.340* 5.23 Profit of 1,030 on sale
2024-11-05SELL-394 5.560* 5.15 Profit of 2,029 on sale
2024-10-28SELL-200 4.910* 4.94 Profit of 988 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of NVRO

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-04-0230,065086,24234.9%
2025-04-0110,409085,50612.2%
2025-03-3133,899075,27045.0%
2025-03-2837,45449680,36146.6%
2025-03-2733,217093,09735.7%
2025-03-26104,6460342,55030.5%
2025-03-25139,3080766,41618.2%
2025-03-2478,2510283,38127.6%
2025-03-21229,1890548,72241.8%
2025-03-20227,25801,110,08920.5%
2025-03-19267,9184901,151,87023.3%
2025-03-18103,3110466,67222.1%
2025-03-17102,72002,238,2564.6%
2025-03-1481,3930700,78711.6%
2025-03-1374,8780294,98425.4%
2025-03-1267,2250241,32227.9%
2025-03-1169,9500275,14725.4%
2025-03-1061,5117,090367,63416.7%
2025-03-0727,51417175,97115.6%
2025-03-0674,5740247,54730.1%
2025-03-05345,73468760,05245.5%
2025-03-0469,885200249,43128.0%
2025-03-0398,077893783,90812.5%
2025-02-2826,2290136,47819.2%
2025-02-2766,1670463,39814.3%
2025-02-2649,6630755,6866.6%
2025-02-2529,9510146,37920.5%
2025-02-2429,59641150,90919.6%
2025-02-2151,30837240,48421.3%
2025-02-20105,005426285,66336.8%
2025-02-19709,6084012,566,98727.6%
2025-02-1818,7510532,4023.5%
2025-02-1436,50138262,94613.9%
2025-02-1337,5750513,1417.3%
2025-02-12110,3320472,11723.4%
2025-02-11158,9860576,37127.6%
2025-02-10120,587700523,40723.0%
2025-02-07148,0015301,227,98112.1%
2025-02-06403,2314948,531,5114.7%
2025-02-0518,017052,48934.3%
2025-02-0413,650083,04616.4%
2025-02-0316,33978119,82513.6%
2025-01-3121,070095,10622.2%
2025-01-3049,0007188,36426.0%
2025-01-2931,0060137,30822.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.


Copyright Market Footprint Ltd. Privacy Policy